WO2007139887A3 - Methods for treating bone or joint inflammation - Google Patents

Methods for treating bone or joint inflammation Download PDF

Info

Publication number
WO2007139887A3
WO2007139887A3 PCT/US2007/012388 US2007012388W WO2007139887A3 WO 2007139887 A3 WO2007139887 A3 WO 2007139887A3 US 2007012388 W US2007012388 W US 2007012388W WO 2007139887 A3 WO2007139887 A3 WO 2007139887A3
Authority
WO
WIPO (PCT)
Prior art keywords
joint
methods
joint inflammation
treating bone
arthritis
Prior art date
Application number
PCT/US2007/012388
Other languages
French (fr)
Other versions
WO2007139887A2 (en
Inventor
Sekhar Boddupalli
Khalid Mahmood
David N Liebowitz
Original Assignee
Cargill Inc
Sekhar Boddupalli
Khalid Mahmood
David N Liebowitz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc, Sekhar Boddupalli, Khalid Mahmood, David N Liebowitz filed Critical Cargill Inc
Publication of WO2007139887A2 publication Critical patent/WO2007139887A2/en
Publication of WO2007139887A3 publication Critical patent/WO2007139887A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention provides methods for promoting bone and joint health with certain compositions described herein or with optionally enriched extracts of plant material comprising such compositions. The present invention provides methods for the treatment or regulation of, bone and joint conditions such as joint inflammation, joint swelling, joint pain, gout, childhood arthritis, lupus arthritis, rheumatoid arthritis, and osteoarthritis.
PCT/US2007/012388 2006-05-22 2007-05-22 Methods for treating bone or joint inflammation WO2007139887A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80261406P 2006-05-22 2006-05-22
US60/802,614 2006-05-22

Publications (2)

Publication Number Publication Date
WO2007139887A2 WO2007139887A2 (en) 2007-12-06
WO2007139887A3 true WO2007139887A3 (en) 2008-05-08

Family

ID=38606629

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/012388 WO2007139887A2 (en) 2006-05-22 2007-05-22 Methods for treating bone or joint inflammation

Country Status (1)

Country Link
WO (1) WO2007139887A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125631A (en) * 2018-11-13 2019-01-04 张洪搏 Chinese medicine composition and preparation method thereof with liver kidney regulatory function

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
CN102325535A (en) * 2009-02-23 2012-01-18 帝斯曼知识产权资产管理有限公司 Extraits de cajanus et glucosamine pour troubles inflammatoires
WO2011019375A1 (en) 2009-08-10 2011-02-17 Teva Pharmaceutical Industries Ltd. Treatment of bdnf-related disorders using laquinimod
NZ602510A (en) 2010-03-03 2014-11-28 Teva Pharma Treatment of lupus nephritis using laquinimod
KR20130014523A (en) 2010-03-03 2013-02-07 테바 파마슈티컬 인더스트리즈 리미티드 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
BR112012022064A2 (en) * 2010-03-03 2015-09-08 Teva Pharma treatment of lupus arthritis using laquinimod
GB201007071D0 (en) * 2010-04-28 2010-06-09 Nordic Bioscience As Treatment of cartilage resorption
KR101681683B1 (en) * 2010-07-02 2016-12-01 (주)아모레퍼시픽 Composition of skin external application for skin whitening containing extract of flower and fruit of Broussonetia kazinoki
CN102382120B (en) * 2011-09-20 2013-07-10 新乡医学院 11-(2, 4-dichlorophenyl) 12H-benzo[f]-furan [3, 4-b] chromene-10(11H)-ketone and synthetic method thereof
CN102579672A (en) * 2012-03-13 2012-07-18 唐元成 Medicament for treating bone hyperplasia and lumbar disc herniation
CN102895337A (en) * 2012-10-22 2013-01-30 郭玲玲 Medicine for treating gout
TWI718432B (en) * 2013-06-17 2021-02-11 美商優力竟股份有限公司 Compositions and methods for joint health
CN104127633A (en) * 2014-07-24 2014-11-05 黄武 Traditional Chinese medicine composition extract for treating hyperosteogeny and preparation method thereof
CN104383030A (en) * 2014-12-08 2015-03-04 闫新玲 Traditional Chinese medicine preparation for treating gonarthromeningitis
CN104524220A (en) * 2015-01-09 2015-04-22 杨茹芹 Traditional Chinese medicine composition for treating qi depression blood stagnation type scleroderma
CN104587393A (en) * 2015-01-14 2015-05-06 姜丽莎 Traditional Chinese medicine composition for treating knee-joint hyperostosis
CN104886562A (en) * 2015-05-07 2015-09-09 西双版纳傣赞源生物科技有限公司 Alcohol toxin clearing composition and preparation method thereof
KR101987971B1 (en) * 2018-01-02 2019-06-11 한국생명공학연구원 Composition for Preventing or Treating Arthritis, Comprising Aromatic Ketone Compound, Melicope pteleifolia Extract, or Fraction Thereof Containing the Same
US11090365B2 (en) 2019-08-08 2021-08-17 SVK Herbal Corporation Composition and methods for treating bone and joint disease including extract from crocodilos reptilia and herbs
KR102296780B1 (en) * 2019-08-28 2021-09-01 전남대학교산학협력단 Phamaceutical Composition Comprising an Extract of Artemisia scoparia for Preventing or Treating Metabolic Bone Disease-induced Bone Loss
WO2021102569A1 (en) * 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabinoid derivatives
KR102287247B1 (en) * 2020-12-24 2021-08-06 양소현 The composition of joint nutritional supplement for companion animals
KR102491584B1 (en) * 2021-02-10 2023-01-26 전남대학교 산학협력단 Composition for Improving, Preventing or Treating Bone Disease
KR102432654B1 (en) * 2021-08-31 2022-08-16 주식회사 캘러스 Feed additives for improve joint disease in companion animal

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908629A (en) * 1989-09-15 1999-06-01 The General Hospital Corporation Conjugate vaccine for group B streptococcus
WO2003094947A1 (en) * 2002-05-09 2003-11-20 Chemon Inc. Herbal extract for prophylaxis or treatment of inflammatory diseases and process for preparation thereof
US20040052870A1 (en) * 2000-12-15 2004-03-18 Obukowicz Mark G. Selective cox-2 inhibition from edible plant extracts
KR20040079742A (en) * 2003-03-10 2004-09-16 바이오코트(주) Food composition for preventing and treating inflammatory diseases by inhibition of TNF alpha and mast cell migration and process for preparation thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908629A (en) * 1989-09-15 1999-06-01 The General Hospital Corporation Conjugate vaccine for group B streptococcus
US20040052870A1 (en) * 2000-12-15 2004-03-18 Obukowicz Mark G. Selective cox-2 inhibition from edible plant extracts
WO2003094947A1 (en) * 2002-05-09 2003-11-20 Chemon Inc. Herbal extract for prophylaxis or treatment of inflammatory diseases and process for preparation thereof
KR20040079742A (en) * 2003-03-10 2004-09-16 바이오코트(주) Food composition for preventing and treating inflammatory diseases by inhibition of TNF alpha and mast cell migration and process for preparation thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GOOSSENS, JO F. ET AL: "High-performance liquid chromatography of isoflavonoid phytoalexins in French bean ( Phaseolus vulgaris)", JOURNAL OF CHROMATOGRAPHY , 267(2), 439-42 CODEN: JOCRAM; ISSN: 0021-9673, 1983, XP002457148 *
HIRAGA Y ET AL: "HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF LICORICE GLYCYRRHIZA-SPP EXTRACTS", JOURNAL OF CHROMATOGRAPHY, vol. 292, no. 2, 1984, pages 451 - 453, XP002457147 *
KIM, HYOUNG JA ET AL: "Identification of tyrosinase inhibitors from Glycyrrhiza uralensis", PLANTA MEDICA , 71(8), 785-787 CODEN: PLMEAA; ISSN: 0032-0943, 2005, XP002457146 *
LAUPATTARKSEM ET AL: "Anti-inflammatory isoflavonoids from the stems of Derris scandens", PLANTA MEDICA, vol. 26, no. 4, August 2004 (2004-08-01), XP018001359 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109125631A (en) * 2018-11-13 2019-01-04 张洪搏 Chinese medicine composition and preparation method thereof with liver kidney regulatory function

Also Published As

Publication number Publication date
WO2007139887A2 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
WO2007139887A3 (en) Methods for treating bone or joint inflammation
WO2008023063A3 (en) Treatment of cartilage disorders with fgf-18
WO2008088685A3 (en) Systems and methods for the fixation or fusion of bone
WO2008005303A3 (en) Thiazolopyrimidine modulators of trpv1
HK1137366A1 (en) Pharmaceutical compositions comprising activin-actriia antagonists and use thereof in preventing or treating multiple myeloma
WO2008057217A3 (en) Spinal cross connectors
WO2008036502A3 (en) Artificial spinal disc
EP2010214A4 (en) Uses and compositions for treatment of rheumatoid arthritis
WO2010104983A3 (en) Biological tissue connection and repair devices and methods of using same
MX351286B (en) Truncated actriib-fc fusion proteins.
WO2007092622A3 (en) Compositions and methods for treating bone
EP1997882A4 (en) Novel bacterium and method for control of plant disease using the same
WO2007104053A3 (en) 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
WO2008130989A3 (en) Prosthetic implants
WO2007047112A3 (en) Anti-myostatin antibodies
WO2008148873A3 (en) Hydroxyproline compositions and uses thereof
WO2011008773A3 (en) Mesenchymal stem cell differentiation
MX2012006206A (en) Combination preparations comprising exosomes and corticosteroid.
WO2010140061A3 (en) Formulations for the treatment of deep tissue pain
WO2007038749A3 (en) Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
PT2054045E (en) Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain
WO2008100621A3 (en) Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
MY148277A (en) Treatment of cartilage disorders with fgf-18
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
WO2008074935A3 (en) Biologically active compositions, methods for producing the same and biological applications

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07795288

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07795288

Country of ref document: EP

Kind code of ref document: A2